Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/116069
Title: Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database
Authors: Stacchiotti, Silvia
Provenzano, Salvatore
Dagrada, Gianpaolo
Negri, Tiziana
Brich, Silvia
Basso, Umberto 
Brunello, Antonella 
Grosso, Federica
Galli, Luca
Palassini, Elena
Libertini, Michela
Colia, Vittoria
Gronchi, Alessandro
Dei Tos, Angelo P
Crippa, Flavio
Morosi, Carlo
Pilotti, Silvana
Casali, Paolo G
Keywords Plus: TREATMENT OPTIONS;SOFT-TISSUE;PHASE-II;RAPAMYCIN;TUMORS;ACTIVATION;SARCOMA;FUSION
Mesh headings: Antibiotics, Antineoplastic;Hemangioendothelioma, Epithelioid;Intracellular Signaling Peptides and Proteins;Sirolimus
Secondary Mesh headings: Adult;Aged;Ascitic Fluid;Databases, Factual;Disease Progression;Disease-Free Survival;Gene Rearrangement;Humans;Italy;Male;Middle Aged;Pleural Effusion;Response Evaluation Criteria in Solid Tumors;Retrospective Studies;Survival Rate;Transcription Factors;Treatment Outcome;Young Adult
Issue Date: 2016
Publisher: SPRINGER
Journal: Annals of surgical oncology 
Abstract: 
The aim of this study was to report on sirolimus activity in a series of patients with hemangioendothelioma (HE) treated at the National Cancer Institute, Milan (Istituto Nazionale Tumori; INT) and within the Italian Rare Cancer Network ("Rete Tumori Rari"; RTR).
URI: http://hdl.handle.net/20.500.12857/116069
ISSN: 10689265
DOI: 10.1245/s10434-016-5331-z
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

10
Last Week
0
Last month
checked on Aug 7, 2021

SCOPUSTM   
Citations 20

27
checked on Sep 1, 2020

WEB OF SCIENCETM
Citations

36
checked on Dec 4, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.